CHICAGO and VANCOUVER, British Columbia, July 02, 2025 (GLOBE NEWSWIRE) -- Green Thumb Industries Inc. (Green Thumb) (CSE: GTII) (OTCQX: GTBIF), a leading national cannabis consumer packaged goods company and owner of RISE Dispensaries , today announced it will release second quarter 2025 financial results after the market closes on Wednesday, August 6, 2025.
The U.S. cannabis industry continues to expand as legalization momentum builds. In 2025, total market revenue is projected to exceed $45 billion. Additionally, over two-thirds of Americans now live in a state where cannabis is legal. Many operators are scaling rapidly to meet this demand. Meanwhile, new legislation could further loosen restrictions at the federal level. These shifts present unique opportunities for investors focused on growth sectors. However, volatility remains high. Therefore, traders must approach cannabis stocks with discipline. Technical analysis plays a vital role here. Watching for volume spikes, trend confirmations, and breakout patterns can help pinpoint setups. Still, no setup is complete without a risk plan. Stop-loss levels should be pre-determined. Proper position sizing is also key. These tools allow traders to control downside while remaining flexible. As we begin the week, several top marijuana stocks appear promising based on their chart setups and recent price behavior.
The U.S. cannabis market continues to grow at a rapid pace. Legal sales are expected to reach $44 billion in 2025. By 2030, estimates suggest the market could top $75 billion. This ongoing expansion is fueled by strong consumer demand and new state-level legalization. Public support remains high, with nearly nine out of ten Americans favoring legalization. Moreover, recent trends like hemp-derived THC drinks are gaining popularity across the country. Major cannabis brands are also entering this space, hoping to capture early market share. However, regulators are beginning to increase oversight on labeling and distribution. Despite some hurdles, momentum within the industry remains strong. Many cannabis stocks are beginning to consolidate near key technical levels. Therefore, this week presents a critical time to monitor high-performing names in the space.
12 Aug 2025 (In 1 month) Date | | 0.04 Cons. EPS | - EPS |
6 May 2025 Date | | 0.04 Cons. EPS | 0.05 EPS |
26 Feb 2025 Date | | 0.07 Cons. EPS | 0.07 EPS |
7 Nov 2024 Date | | 0.06 Cons. EPS | 0.04 EPS |
6 Nov 2024 Date | | 0.06 Cons. EPS | - EPS |
12 Aug 2025 (In 1 month) Date | | 0.04 Cons. EPS | - EPS |
6 May 2025 Date | | 0.04 Cons. EPS | 0.05 EPS |
26 Feb 2025 Date | | 0.07 Cons. EPS | 0.07 EPS |
7 Nov 2024 Date | | 0.06 Cons. EPS | 0.04 EPS |
6 Nov 2024 Date | | 0.06 Cons. EPS | - EPS |
Medical Devices Industry | Healthcare Sector | Mr. Hisashi Ietsugu CEO | OTCQX Exchange | CA39342L1085 ISIN |
DE Country | - Employees | - Last Dividend | 7 Jan 2010 Last Split | - IPO Date |
Green Thumb Industries Inc. is a leading entity in the cannabis industry within the United States, focusing on the manufacturing, distribution, marketing, and sales of cannabis products. The company caters to both medical and adult-use markets and operates through two primary segments: Retail and Consumer Packaged Goods. Founded in 2014, with its headquarters in Chicago, Illinois, Green Thumb Industries has been at the forefront of expanding access to safe and effective cannabis products across the nation. The company's operations include not only the supply of cannabis flower and processed products but also the ownership and management of retail stores and direct-to-consumer delivery services. This integrated approach allows Green Thumb to maintain strict quality control, ensuring that consumers receive premium products tailored to a variety of needs and preferences.